Itzchak Angel

1.1k total citations
33 papers, 897 citations indexed

About

Itzchak Angel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, Itzchak Angel has authored 33 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 7 papers in Endocrine and Autonomic Systems. Recurrent topics in Itzchak Angel's work include Neuroscience and Neuropharmacology Research (8 papers), Regulation of Appetite and Obesity (7 papers) and Receptor Mechanisms and Signaling (7 papers). Itzchak Angel is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Regulation of Appetite and Obesity (7 papers) and Receptor Mechanisms and Signaling (7 papers). Itzchak Angel collaborates with scholars based in France, United States and Israel. Itzchak Angel's co-authors include Steven M. Paul, Jonathan E. Friedman, Daniel M. Michaelson, Joel E. Kleinman, Jae‐Young Koh, Joo‐Yong Lee, Steven M. Paul, Salomón Z. Langer, Stéfano Palea and Aaron Janowsky and has published in prestigious journals such as PLoS ONE, Biochemistry and Brain Research.

In The Last Decade

Itzchak Angel

32 papers receiving 869 citations

Peers

Itzchak Angel
Jeffrey S. Nissen United States
Char‐Chang Shieh United States
Karen Benwell United Kingdom
Katie L. Anderson United States
Jeffrey S. Nissen United States
Itzchak Angel
Citations per year, relative to Itzchak Angel Itzchak Angel (= 1×) peers Jeffrey S. Nissen

Countries citing papers authored by Itzchak Angel

Since Specialization
Citations

This map shows the geographic impact of Itzchak Angel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itzchak Angel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itzchak Angel more than expected).

Fields of papers citing papers by Itzchak Angel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itzchak Angel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itzchak Angel. The network helps show where Itzchak Angel may publish in the future.

Co-authorship network of co-authors of Itzchak Angel

This figure shows the co-authorship network connecting the top 25 collaborators of Itzchak Angel. A scholar is included among the top collaborators of Itzchak Angel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itzchak Angel. Itzchak Angel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angel, Itzchak, et al.. (2025). KETAMIR-2, a new molecular entity and novel ketamine analog. Frontiers in Pharmacology. 16. 1606976–1606976.
2.
Haber, Adi, Itzchak Angel, Atif Mahammed, & Zeev Gross. (2013). Combating diabetes complications by 1-Fe, a corrole-based catalytic antioxidant. Journal of Diabetes and its Complications. 27(4). 316–321. 27 indexed citations
3.
Barac, Yaron D., Orit Bar‐Am, Esti Liani, et al.. (2012). I1 Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline. PLoS ONE. 7(11). e47890–e47890. 12 indexed citations
4.
Alchanati, Iris, Galit Cohen, Haim Barr, et al.. (2009). The E3 Ubiquitin-Ligase Bmi1/Ring1A Controls the Proteasomal Degradation of Top2α Cleavage Complex – A Potentially New Drug Target. PLoS ONE. 4(12). e8104–e8104. 71 indexed citations
5.
Rosenberg, G, et al.. (2005). Clinical pharmacology of DP‐b99 in healthy volunteers: First administration to humans. British Journal of Clinical Pharmacology. 60(1). 7–16. 18 indexed citations
6.
Lee, Joo‐Yong, et al.. (2004). The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice. Neurobiology of Aging. 25(10). 1315–1321. 159 indexed citations
7.
Angel, Itzchak, et al.. (2002). Metal ion chelation in neurodegenerative disorders. Drug Development Research. 56(3). 300–309. 37 indexed citations
8.
Palea, Stéfano, et al.. (1998). The adrenergic, cholinergic and NANC nerve‐mediated contractions of the female rabbit bladder neck and proximal, medial and distal urethra. British Journal of Pharmacology. 123(8). 1517–1524. 13 indexed citations
9.
Angel, Itzchak, et al.. (1997). Analysis of α1-adrenoceptors in rabbit lower urinary tract and mesenteric artery. European Journal of Pharmacology. 327(1). 25–32. 37 indexed citations
10.
Palea, Stéfano & Itzchak Angel. (1997). The effect of ovariectomy on the contractile response of the rat isolated detrusor muscle and urethra. Life Sciences. 61(1). PL21–PL26. 18 indexed citations
11.
Angel, Itzchak, et al.. (1996). Characterisation of the 5-HT receptor potentiating neurotransmission in rabbit bladder. European Journal of Pharmacology. 318(2-3). 425–428. 16 indexed citations
12.
Jonas, Jean‐Christophe, Maria José García‐Barrado, Itzchak Angel, & Jean‐Claude Henquin. (1994). The imidazoline SL 84.0418 shows stereoselectivity in blocking α2-adrenoceptors but not ATP-sensitive K+ channels in pancreatic B-cells. European Journal of Pharmacology. 264(1). 81–84. 13 indexed citations
13.
Jonas, Jean‐Christophe, Timothy Plant, Itzchak Angel, Salomón Z. Langer, & Jean‐Claude Henquin. (1994). In vitro stimulation of insulin release by SL 84.0418, a new α2-adrenoceptor antagonist. European Journal of Pharmacology. 254(1-2). 27–33. 12 indexed citations
14.
Angel, Itzchak, et al.. (1992). Regulation of the anorectic drug recognition site during glucoprivic feeding. Brain Research Bulletin. 28(2). 201–207. 4 indexed citations
15.
Angel, Itzchak, et al.. (1991). Impairment of glucostatic, adrenergic and serotoninergic feeding parallels the lack of glucoprivic signals in the golden hamster. Brain Research Bulletin. 27(3-4). 353–358. 6 indexed citations
16.
Angel, Itzchak. (1990). Central Receptors and Recognition Sites Mediating the Effects of Monoamines and Anorectic Drugs on Feeding Behavior. Clinical Neuropharmacology. 13(5). 361–391. 22 indexed citations
17.
Angel, Itzchak, et al.. (1989). Coupling between hypothalamic α2-adrenoceptors and [3H]mazindol binding site in response to several hyperglycaemic stimuli in mice. Brain Research. 490(2). 367–372. 12 indexed citations
18.
Angel, Itzchak, Aaron Janowsky, & Steven M. Paul. (1989). The effect of serotonergic and dopaminergic lesions on sodium-sensitive [3H]mazindol binding in rat hypothalamus and corpus striatum. Brain Research. 503(2). 339–341. 3 indexed citations
19.
Angel, Itzchak & Salomón Z. Langer. (1988). Adrenergic-induced hyperglycemia in anaesthetized rats: involvement of peripheral α2-adrenoceptors. European Journal of Pharmacology. 154(2). 191–196. 32 indexed citations
20.
Angel, Itzchak, et al.. (1987). Characterization of [3H]Mazindol Binding in Rat Brain: Sodium‐Sensitive Binding Correlates with the Anorectic Potencies of Phenylethylamines. Journal of Neurochemistry. 48(2). 491–497. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026